Iasis Molecular Science products

Our platform No. 1 antiseptics are a family of novel silver-based complexes for the treatment of wound infections and for use as the active component of antimicrobial medical device coatings. These antiseptics offer excellent potency against drug-resistant pathogens, little concern of selection for resistance, lower cellular toxicity, and process benefits not found with commercial antiseptics. Currently marketed antiseptic solutions are toxic to human tissue, are not selective for microorganisms, and often interrupt healing processes where applied.

Our platform No. 2 antimicrobial additives can be broadly applicable across medical, consumer and industrial markets.  A wide variety of derivatives have been synthesized.  In the medical device space silver (Ag+) and quaternary ammonium compounds (QACs) have been explored. Modified acrylic latex enamel paint with various actives has been shown to be extensively antimicrobial, antiviral and antifungal, eradicating >99.99% or more of pathogens. In the last decade, interest in silver nanoparticles (Ag NPs) has increased due to their unique antimicrobial activities.  Silver nanoparticles are now the most common commercialized nano-technological product on the market.  They are widely used in many products including advanced wound dressings.  However, there is an increasing concern related to the biological impact of the use of nanoparticles on a larger global scale, and the possible risks to both human and environmental  health.